TICO Trial: Ticagrelor monotherapy vs. extended dual anti-platelet therapy after placement of drug-eluting stents resulted in a reduction in adverse major bleeding events
1. Patients status-post placement of drug-eluting stents (DES) for acute coronary syndrome received three months of Ticagrelor and Aspirin dual-antiplatelet ...